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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.1 Reaction progress was monitored by thin-
layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck 
silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence 
quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel 
(particle size 40–63 nm) was used for flash chromatography.  1H NMR spectra were recorded on 
Varian Inova 500 MHz and Bruker 400 MHz spectrometers and are reported relative to residual 
CHCl3 (δ 7.26 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz spectrometer 
(125 MHz) and Bruker 400 MHz spectrometers (100 MHz) and are reported relative to CHCl3 
(δ 77.16 ppm). Data for 1H NMR are reported as follows: chemical shift (δ ppm) (multiplicity, 
coupling constant (Hz), integration).  Multiplicities are reported as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br 
d = broad doublet.  Data for 13C NMR are reported in terms of chemical shifts (δ ppm).  IR 
spectra were obtained by use of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 
FTIR spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm–1).  Optical rotations were measured with a Jasco P-2000 polarimeter operating 
on the sodium D-line (589 nm), using a 100 mm path-length cell.  Analytical SFC was performed 
with a Mettler SFC supercritical CO2 analytical chromatography system utilizing Chiralpak (AD-
H, AS-H or IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries, Ltd. High resolution mass spectra (HRMS) were obtained from 
Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray ionization 
(ESI+), atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: 
ESI-APCI+), or obtained from Caltech mass spectrometry laboratory. 
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa Aesar and 
used as received unless otherwise stated. Ligands (S)-L1,2 (S)-L2,3 (R,R)-L4,4 and (R,R)-L55 
and substrate 1a6 were prepared by known methods. 
List of Abbreviations: 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, TBME – tert-butyl methyl ether, IPA – isopropanol 
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General Procedure for Pd-Catalyzed Allylic Alkylation Reactions 
 
In a nitrogen-filled glovebox, Pd2(pmdba)3 (1.0 mol %, 2.2 mg) and (R,R)-L5 (2.4 mol %, 3.9 
mg) were added to a 1 dram vial followed by 1.0 mL of TBME.  The resulting mixture was 
stirred at 25 °C for 30 minutes at which time a solution of β-ketoester substrate (0.2 mmol) in 1.0 
mL TBME was added.  The vial was then sealed with a Teflon-lined cap and electrical tape, 
removed from the glovebox, and stirred at 25 °C for 12 h.  The crude reaction mixture was 
filtered through Celite®, and the Celite® rinsed with Et2O. The crude product was purified by 
silica gel flash chromatography to provide the desired alkylation product. 
 	
  
 
(S)-3-allyl-3-benzyltetrahydro-4H-thiopyran-4-one (2a) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (45.2 mg, 
92% yield); 94% ee, [α]D25 +11.0 (c 1.05, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.32–7.19 (m, 
3H), 7.17–7.10 (m, 2H), 5.72 (dddd, J = 16.9, 10.3, 7.9, 6.7 Hz, 1H), 5.17–5.07 (m, 2H), 3.14 (d, 
J = 13.8 Hz, 1H), 3.02 (d, J = 13.8 Hz, 1H), 2.95–2.85 (m, 2H), 2.83–2.69 (m, 4H), 2.56 (ddt, J = 
14.4, 7.8, 1.2 Hz, 1H), 2.47 (ddt, J = 14.4, 6.7, 1.4 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 
211.1, 136.7, 133.2, 130.8, 128.3, 126.8, 119.2, 54.0, 41.6, 40.2, 38.8, 38.0, 29.7; IR (Neat Film, 
NaCl) 3062, 3028, 2976, 2946, 2913, 1703, 1638, 1604, 1582, 1495, 1453, 1434, 1419, 1312, 
1274, 1223, 1129, 1086, 1031, 988, 965, 918, 806, 750, 726, 703 cm–1; HRMS (FAB+) m/z 
calc’d for C15H19OS [M+H]+: 247.1157, found 247.1168; SFC Conditions: 15% IPA, 2.5 
mL/min, Chiralcel OJ-H column, λ = 210 nm, tR (min): minor = 2.87, major = 3.48. 
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Procedure for Preparatory Scale Preparation of 2a 
In a nitrogen-filled glovebox, Pd2(pmdba)3 (1.0 mol %, 33.0 mg) and (R,R)-L5 (2.4 mol %, 58.5 
mg) were dissolved in 15.0 mL of TBME, and the resulting mixture was stirred at 25 °C.  After 
30 minutes, a solution of β-ketoester substrate 1a (3.0 mmol, 871.1 mg) in 15.0 mL TBME was 
added, and the reaction flask sealed and removed from the glovebox.  After stirring at 25 °C for 
12 h, the crude reaction mixture was filtered through Celite®, and the Celite® rinsed with Et2O. 
The crude product was purified by silica gel flash chromatography (10% Et2O in hexanes) to 
provide 2a as a colorless oil (649.0 mg, 88% yield): 91% ee. 
 
  
(R)-3-allyl-3-methyltetrahydro-4H-thiopyran-4-one (2b) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (25.1 mg, 
74% yield); 93% ee, [α]D25 +33.6 (c 1.25, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.66 (ddt, J = 
17.0, 10.2, 7.4 Hz, 1H), 5.14–5.06 (m, 2H), 2.96–2.83 (m, 2H), 2.81–2.61 (m, 5H), 2.45–2.37 
(m, 1H), 1.19 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 211.9, 132.9, 119.0, 50.0, 41.3, 41.2, 40.9, 
30.6, 22.0; IR (Neat Film, NaCl) 3075, 2976, 2929, 2907, 1703, 1638, 1452, 1432, 1420, 1376, 
1324, 1270, 1221, 1133, 1090, 996, 976, 919, 811 cm–1; HRMS (FAB+) m/z calc’d for C9H14OS 
[M+H]: 170.0765, found 170.0790; SFC Conditions: 2% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): minor = 5.09, major = 6.37. 
 
 
 
(R)-3-allyl-3-ethyltetrahydro-4H-thiopyran-4-one (2c) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (26.0 mg, 
70% yield); 82% ee,* [α]D25 +18.3 (c 0.85, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.71–5.56 (m, 
1H), 5.08 (dddd, J = 13.3, 3.7, 2.2, 1.0 Hz, 2H), 2.94–2.82 (m, 2H), 2.81 (dd, J = 14.1, 1.0 Hz, 
1H), 2.78–2.67 (m, 2H), 2.69–2.59 (m, 1H), 2.54 (ddt, J = 14.3, 7.8, 1.1 Hz, 1H), 2.42–2.33 (m, 
1H), 2.10 (dq, J = 14.9, 7.5 Hz, 1H), 1.66–1.54 (m, 1H), 0.80 (t, J = 7.5 Hz, 3H); 13C NMR (101 
S
O
S
O
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MHz, CDCl3) δ 211.6, 133.3, 118.8, 53.1, 41.3, 39.4, 37.9, 30.4, 26.9, 7.9; IR (Neat Film, NaCl) 
3385, 3075, 2966, 2942, 1702, 1639, 1460, 1433, 1420, 1384, 1339, 1313, 1279, 1244, 1104, 
1082, 996, 918, 812, 782, 723, 673 cm–1; HRMS (FAB+) m/z calc’d for C10H16OS [M+H]: 
184.0922, found 184.0941; SFC Conditions*: 20% IPA, 2.5 mL/min, Chiralpak IC column, λ = 
210 nm, tR (min): minor = 7.87, major = 8.61. 
 
 
 
(S)-3-allyl-3-(2-bromoallyl)tetrahydro-4H-thiopyran-4-one (2d) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (45.2 mg, 
82% yield); 50% ee, [α]D25 +6.2 (c 2.26, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.71–5.59 (m, 
2H), 5.58 (d, J = 1.7 Hz, 1H), 5.16–5.07 (m, 2H), 3.17 (dd, J = 15.3, 0.9 Hz, 1H), 2.96 (d, J = 1.0 
Hz, 1H), 2.94–2.84 (m, 5H), 2.81–2.68 (m, 2H), 2.57 (ddt, J = 14.4, 7.0, 1.3 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δ 210.2, 132.5, 128.3, 122.0, 119.7, 53.1, 45.1, 41.7, 39.3, 38.5, 30.4; IR 
(Neat Film, NaCl) 3387, 3075, 3004, 2976, 2947, 2911, 2836, 1703, 1637, 1623, 1431, 1420, 
1332, 1311, 1275, 1221, 1136, 1105, 993, 966, 920, 897, 809, 739, 673, 618 cm–1; HRMS 
(FAB+) m/z calc’d for C11H16BrOS [M+H]+: 275.0105, found 275.0110; SFC Conditions: 1% 
IPA, 2.5 mL/min, Chiralcel OJ-H column, λ = 210 nm, tR (min): minor = 5.16, major = 5.68. 
 
 
 
(S)-3-allyl-3-(3-methylbut-2-en-1-yl)tetrahydro-4H-thiopyran-4-one (2e) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (33.9 mg, 
76% yield); 78% ee, [α]D25 –6.0 (c 1.65, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.73–5.59 (m, 
1H), 5.11–5.03 (m, 2H), 4.97 (tdq, J = 7.5, 2.9, 1.5 Hz, 1H), 2.87 (t, J = 6.3 Hz, 2H), 2.82–2.74 
(m, 2H), 2.76–2.63 (m, 2H), 2.67–2.53 (m, 2H), 2.41 (ddt, J = 14.1, 7.0, 1.3 Hz, 1H), 2.36–2.27 
(m, 1H), 1.70 (t, J = 1.4 Hz, 3H), 1.62 (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 211.4, 
135.3, 133.3, 118.8, 118.3, 53.6, 41.4, 39.1, 38.8, 32.8, 30.3, 26.2, 18.3; IR (Neat Film, NaCl) 
S
O
Br
S
O
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3387, 3075, 2975, 2912, 2857, 1703, 1638, 1435, 1420, 1377, 1326, 1311, 1274, 1221, 1130, 
1116, 989, 917, 848, 810, 783, 729, 676, 616 cm–1; HRMS (FAB+) m/z calc’d for C13H21OS 
[M+H]+: 225.1313, found 225.1335; SFC Conditions: 2% IPA, 2.5 mL/min, Chiralcel OB-H 
column, λ = 210 nm, tR (min): major = 2.77, minor = 3.21. 
 
 
Ethyl (S)-2-(3-allyl-4-oxotetrahydro-2H-thiopyran-3-yl)acetate (2f) 
Purified by column chromatography (20% Et2O in hexanes) to provide a colorless oil (44.2 mg, 
91% yield); 69% ee, [α]D25 +43.5 (c 2.21, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.68–5.56 (m, 
1H), 5.15–5.07 (m, 2H), 4.08 (qd, J = 7.1, 1.6 Hz, 2H), 3.22 (d, J = 13.8 Hz, 1H), 3.00 (ddd, J = 
13.3, 10.0, 3.8 Hz, 1H), 2.89–2.58 (m, 7H), 2.52 (dd, J = 14.0, 7.9 Hz, 1H), 1.22 (t, J = 7.1 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 209.8, 171.6, 132.1, 119.9, 60.7, 51.6, 41.2, 39.5, 39.2, 
38.4, 30.0, 14.2; IR (Neat Film, NaCl) 3077, 2980, 2916, 1732, 1706, 1639, 1438, 1418, 1372, 
1345, 1317, 1279, 1247, 1222, 1182, 1135, 1114, 1096, 995, 920 cm–1; HRMS (FAB+) m/z 
calc’d for C12H19O3S [M+H]+: 243.1055, found 243.1053; SFC Conditions: 2% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 5.66, minor = 7.67. 
 
 
 
 
Ethyl (S)-2-((3-allyl-4-oxotetrahydro-2H-thiopyran-3-yl)methyl)acrylate (2g) 
Purified by column chromatography (15% Et2O in hexanes) to provide a colorless oil (46.8 mg, 
87% yield); 66% ee, [α]D25 +7.8 (c 2.34, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.26 (d, J = 1.4 
Hz, 1H), 5.72–5.59 (m, 1H), 5.59 (q, J = 1.1 Hz, 1H), 5.13–5.04 (m, 2H), 4.16 (qt, J = 7.2, 1.5 
Hz, 2H), 3.10 (dd, J = 14.2, 1.1 Hz, 1H), 2.93–2.81 (m, 4H), 2.77 (dd, J = 19.6, 1.3 Hz, 1H), 
2.73–2.65 (m, 1H), 2.62 (d, J = 14.1 Hz, 1H), 2.55–2.41 (m, 2H), 1.28 (td, J = 7.2, 1.1 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 210.4, 167.5, 136.9, 133.0, 129.2, 119.2, 61.1, 53.3, 41.5, 38.9, 
38.8, 36.1, 29.7, 14.3; IR (Neat Film, NaCl) 3076, 2979, 2938, 2910, 1712, 1638, 1626, 1436, 
S
O
O
OEt
S
O
CO2Et
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1417, 1369, 1333, 1308, 1276, 1209, 1174, 1159, 1096, 1027, 992, 960, 920, 858.9, 819, 684, 
665 cm–1; HRMS (FAB+) m/z calc’d for C14H21O3S [M+H]+: 269.1211, found 269.1204; SFC 
Conditions: 10% IPA, 3.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 3.04, 
minor = 3.95. 
 
 
(S)-3-benzyl-3-(2-methylallyl)tetrahydro-4H-thiopyran-4-one (2h) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (15.3 mg, 
29% yield); 80% ee, [α]D25 –1.0 (c 0.77, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.31 – 7.24 (m, 
2H), 7.26–7.19 (m, 1H), 7.17–7.11 (m, 2H), 4.89 (m, 1H), 4.70–4.66 (m, 1H), 3.23 (d, J = 13.7 
Hz, 1H), 2.95 (d, J = 13.7 Hz, 1H), 2.92–2.78 (m, 3H), 2.77–2.67 (m, 3H), 2.64 (dd, J = 15.2, 1.1 
Hz, 1H), 2.52 (dd, J = 15.2, 1.2 Hz, 1H), 1.70 (t, J = 1.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
212.1, 141.7, 136.9, 131.0, 128.3, 126.7, 114.9, 53.8, 42.1, 41.5, 40.8, 38.2, 29.7, 25.1; IR (Neat 
Film, NaCl) 3063, 3027, 2915, 1702, 1640, 1494, 1452, 1376, 1311, 1274, 1216, 1124, 1079, 
1031, 988, 897, 808, 748, 704 cm–1; HRMS (FAB+) m/z calc’d for C16H21OS [M+H]+: 261.1313, 
found 261.1323; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralcel OB-H column, λ = 210 nm, tR 
(min): major = 4.18, minor = 5.16. 
 
 
 
 
(S)-3-allyl-3-(4-methylbenzyl)tetrahydro-4H-thiopyran-4-one (2i) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (44.8 mg, 
86% yield); 90% ee, [α]D25 +3.9 (c 2.20, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.08 (d, J = 7.8 
Hz, 2H), 7.02 (d, J = 8.0 Hz, 2H), 5.72 (dddd, J = 16.9, 10.2, 7.8, 6.6 Hz, 1H), 5.16–5.06 (m, 
2H), 3.09 (d, J = 13.9 Hz, 1H), 2.99 (d, J = 13.8 Hz, 1H), 2.89 (m, 2H), 2.83–2.68 (m, 4H), 
2.58–2.49 (m, 1H), 2.46 (ddt, J = 14.4, 6.7, 1.4 Hz, 1H), 2.32 (s, 3H); 13C NMR (101 MHz, 
S
O
S
O
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CDCl3) δ 211.2, 136.3, 133.5, 133.3, 130.6, 129.0, 119.0, 54.0, 41.6, 39.8, 38.7, 38.0, 29.7, 21.1; 
IR (Neat Film, NaCl) 3075, 3049, 3020, 3005, 2946, 2918, 1703, 1638, 1514, 1434, 1419, 1313, 
1274, 1222, 1128, 1115, 989, 919, 830, 797 cm–1; HRMS (FAB+) m/z calc’d for C16H21OS 
[M+H]+: 261.1313, found 261.1331; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralcel OJ-H 
column, λ = 210 nm, tR (min): minor = 3.34, major = 4.14. 
 
 
(S)-3-allyl-3-(4-bromobenzyl)tetrahydro-4H-thiopyran-4-one (2j) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (58.8 mg, 
91% yield); 91% ee, [α]D25 +4.6 (c 2.94, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.42–7.35 (m, 
2H), 7.05–6.98 (m, 2H), 5.68 (dddd, J = 16.9, 10.2, 7.7, 6.7 Hz, 1H), 5.17–5.06 (m, 2H), 3.11 (d, 
J = 13.8 Hz, 1H), 2.95–2.84 (m, 3H), 2.78–2.69 (m, 4H), 2.55 (ddt, J = 14.4, 7.7, 1.2 Hz, 1H), 
2.43 (ddt, J = 14.3, 6.7, 1.3 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 210.7, 135.8, 132.8, 132.5, 
131.4, 120.8, 119.4, 53.8, 41.5, 39.6, 38.9, 37.9, 29.7; IR (Neat Film, NaCl) 3075, 2946, 2914, 
1703, 1638, 1487, 1434, 1404, 1313, 1274, 1073, 1012, 989, 921, 837, 788 cm–1; HRMS (FAB+) 
m/z calc’d for C15H18BrOS [M+H]+: 325.0262, found 325.0265; SFC Conditions: 7% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 11.06, major = 11.92. 
 
 
(S)-3-allyl-3-(4-fluorobenzyl)tetrahydro-4H-thiopyran-4-one (2k) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (43.9 mg, 
83% yield); 91% ee, [α]D25 +9.3 (c 2.20, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.14–7.06 (m, 
2H), 7.00–6.91 (m, 2H), 5.69 (dddd, J = 17.0, 10.3, 7.7, 6.7 Hz, 1H), 5.17–5.06 (m, 2H), 3.13 (d, 
J = 14.0 Hz, 1H), 2.95 (d, J = 14.0 Hz, 1H), 2.88 (dd, J = 7.6, 5.0 Hz, 2H), 2.79–2.70 (m, 4H), 
2.58–2.49 (m, 1H), 2.44 (ddt, J = 14.4, 6.7, 1.4 Hz, 1H); 19F (282 MHz, CDCl3) δ –116.25 (tt, J  
= 8.8, 5.4 Hz); 13C NMR (101 MHz, CDCl3) δ 210.9, 161.9 (d, J = 245.1 Hz), 133.0, 132.3 (d, J 
S
O
Br
S
O
F
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= 3.3 Hz), 132.2 (d, J = 7.9 Hz), 119.3, 115.2 (d, J = 21.0 Hz), 53.9, 41.5, 39.4, 38.8, 37.9, 29.7; 
IR (Neat Film, NaCl) 3075, 2947, 2915, 1703, 1638, 1604, 1509, 1435, 1417, 1335, 1314, 1275, 
1223, 1160, 1130, 1098, 1016, 988, 965, 921, 843, 813, 772 cm–1; HRMS (FAB+) m/z calc’d for 
C15H18FOS [M+H]+: 265.1062, found 265.1055; SFC Conditions: 10% IPA, 2.5 mL/min, 
Chiralcel OB-H column, λ = 210 nm, tR (min): major = 2.70, minor = 3.75. 
 
 
 
(S)-3-allyl-3-(4-(trifluoromethyl)benzyl)tetrahydro-4H-thiopyran-4-one (2l) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (50.5 mg, 
80% yield); 93% ee, [α]D25 +12.5 (c 2.53, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.0 
Hz, 2H), 7.26 (d, J = 8.0 Hz, 2H), 5.69 (dddd, J = 17.0, 10.2, 7.7, 6.8 Hz, 1H), 5.19–5.09 (m, 
2H), 3.22 (d, J = 13.7 Hz, 1H), 3.03 (d, J = 13.8 Hz, 1H), 2.89 (t, J = 6.2 Hz, 2H), 2.84–2.67 (m, 
4H), 2.60 (ddt, J = 14.4, 7.7, 1.2 Hz, 1H), 2.44 (ddt, J = 14.4, 6.7, 1.3 Hz, 1H); 19F NMR (282 
MHz, CDCl3) δ –62.48 (s); 13C NMR (101 MHz, CDCl3) δ 210.5, 141.1 (d, J = 1.4 Hz), 132.6, 
131.1, 129.1 (q, J = 32.5 Hz), 125.2 (q, J = 3.7 Hz), 122.9 (q, J = 272.7), 119.6, 53.9, 41.5, 40.0, 
38.9, 38.1, 29.7; IR (Neat Film, NaCl) 3076, 2917, 1703, 1638, 1618, 1436, 1417, 1326, 1275, 
1165, 1123, 1068, 1019, 922, 856 cm–1; HRMS (FAB+) m/z calc’d for C16H18F3OS [M+H]+: 
315.1030, found 315.1042; SFC Conditions: 2% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 
210 nm, tR (min): major = 10.24, minor = 11.19. 
 
 
General Procedure for Preparation of Thiopyranone β-Ketoesters Substrates 
 
 
To an oven dried 20 mL vial was added NaH (3 mmol) and the vial evacuated and backfilled 
with argon three times.  To the vial was added anhydrous DMF (1.0 mL), toluene (1.0 mL), and 
alkyl bromide (3 mmol) and the resulting suspension stirred for 5 minutes.  A solution of S1 (2 
mmol) in anhydrous toluene (1.0 mL) was then added dropwise over 10 min.  Following the 
S
O
CF3
S
O
CO2allyl
+ R–Br (1.5 equiv)
NaH (2 equiv)
DMF/toluene, 25 °C
S
O
CO2allyl
S1
R
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addition, the reaction was continued until all S1 was consumed as seen by TLC.  If necessary, 
additional toluene (1.0 to 2.0 mL) was added to ensure proper stirring of the reaction mixture.  
After diluting with Et2O, the reaction was quenched with 1.0 M HCl, and the layers separated.  
The aqueous layer was extracted with Et2O, and the combined organic layers were washed with 
water then brine, and dried over Na2SO4.  The resulting crude residue was then purified by silica 
gel flash chromatography to provide the desired product. 
 
 
  
Allyl 3-methyl-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1b)  
Purified by column chromatography (15% Et2O in hexanes) to provide a colorless oil (224.3 mg, 
52% yield); 1H NMR (500 MHz, CDCl3) δ 5.91 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.34 (dq, J = 
17.2, 1.5 Hz, 1H), 5.26 (dq, J = 10.4, 1.3 Hz, 1H), 4.74–4.62 (m, 2H), 3.33 (dd, J = 13.9, 2.9 Hz, 
1H), 3.01–2.82 (m, 3H), 2.84–2.76 (m, 1H), 2.71 (d, J = 13.9 Hz, 1H), 1.41 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 205.5, 171.8, 131.5, 119.1, 66.3, 59.2, 42.9, 40.0, 30.8, 21.0; IR (Neat Film, 
NaCl) 3086, 2985, 2937, 1731, 1714, 1649, 1454, 1417, 1374, 1358, 1315, 1294, 1277, 1233, 
1192, 1160, 1125, 1100, 1064, 974, 938, 855, 817, 770, 738, 713, 682 cm–1; HRMS (FAB+) m/z 
calc’d for C10H15O3S [M+H]+: 215.0742, found 215.0741. 
 
 
Allyl 3-ethyl-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1c) 
Purified by column chromatography (7% Et2O in hexanes) to provide a colorless oil (157.4 mg, 
35% yield); 1H NMR (500 MHz, CDCl3) δ 5.92 (ddt, J = 17.3, 10.5, 5.8 Hz, 1H), 5.35 (dq, J = 
17.1, 1.5 Hz, 1H), 5.27 (dq, J = 10.3, 1.2 Hz, 1H), 4.75–4.62 (m, 2H), 3.30 (dd, J = 13.9, 2.9 Hz, 
1H), 3.01–2.89 (m, 2H), 2.89–2.82 (m, 1H), 2.81–2.70 (m, 2H), 2.08–1.97 (m, 1H), 1.74 (dq, J = 
14.6, 7.5 Hz, 1H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 205.5, 170.8, 131.6, 
119.2, 66.1, 63.4, 43.4, 38.4, 31.0, 27.6, 9.3; IR (Neat Film, NaCl) 3085, 2967, 2940, 2883, 
1727, 1712, 1460, 1425, 1381, 1360, 1308, 1270, 1248, 1227, 1196, 1149, 1128, 986, 971, 936, 
S
O
CO2allyl
S
O
CO2allyl
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814, 796, 779, 732, 682 cm–1; HRMS (FAB+) m/z calc’d for C11H17O3S [M+H]+: 229.0898, 
found 229.0894. 
 
 
 
 
Allyl 3-(2-bromoallyl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1d) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (330.1 mg, 
52% yield); 1H NMR (500 MHz, CDCl3) δ 5.99–5.86 (m, 1H), 5.68 (dt, J = 1.7, 0.8 Hz, 1H), 
5.60 (d, J = 1.7 Hz, 1H), 5.37 (dq, J = 17.2, 1.5 Hz, 1H), 5.27 (dq, J = 10.4, 1.3 Hz, 1H), 4.75–
4.63 (m, 2H), 3.53 (dd, J = 14.0, 2.7 Hz, 1H), 3.23 (dd, J = 15.0, 0.7 Hz, 1H), 3.02 (dd, J = 15.0, 
0.7 Hz, 1H), 3.01–2.72 (m, 5H); 13C NMR (101 MHz, CDCl3) δ 203.7, 169.2, 131.4, 126.3, 
122.8, 119.4, 66.7, 62.5, 44.7, 43.3, 37.7, 30.6; IR (Neat Film, NaCl) 3085, 2952, 2923, 1714, 
1649, 1624, 1425, 1360, 1313, 1298, 1279, 1263, 1196, 1143, 1115, 1054, 985, 969, 936, 901, 
854, 839, 814, 736, 683 cm–1; HRMS (FAB+) m/z calc’d for C12H14O3S81Br [(M+H)–H2]+: 
318.9827, found 318.9828. 
 
 
 
 
Allyl 3-(3-methylbut-2-en-1-yl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1e)  
Purified by column chromatography (15% Et2O in hexanes) to provide a colorless oil (369.8 mg, 
69% yield); 1H NMR (500 MHz, CDCl3) δ 5.90 (ddt, J = 17.1, 10.4, 5.8 Hz, 1H), 5.34 (dq, J = 
17.2, 1.5 Hz, 1H), 5.25 (dq, J = 10.4, 1.2 Hz, 1H), 5.06 (dddt, J = 8.4, 7.0, 2.9, 1.5 Hz, 1H), 
4.69–4.61 (m, 2H), 3.30 (dd, J = 13.9, 2.8 Hz, 1H), 2.98–2.86 (m, 2H), 2.90–2.81 (m, 1H), 2.84–
2.72 (m, 2H), 2.65–2.49 (m, 2H), 1.68 (m, J = 1.3 Hz, 3H), 1.70–1.59 (m, 3H); 13C NMR (126 
MHz, CDCl3) δ 205.3, 170.5, 135.8, 131.6, 119.1, 118.0, 66.2, 63.3, 43.4, 37.9, 33.0, 30.8, 26.1, 
S
O
CO2allyl
Br
S
O
CO2allyl
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18.1; IR (Neat Film, NaCl) 2912, 1712, 1426, 1377, 1315, 1263, 1223, 1185, 1114, 933 cm–1; 
HRMS (FAB+) m/z calc’d for C14H21O3S [M+H]+: 269.1211, found 269.1204. 
 
 
Allyl 3-(2-ethoxy-2-oxoethyl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1f) 
Purified by column chromatography (30% Et2O in hexanes) to provide a colorless oil (472.0 mg, 
83% yield); 1H NMR (500 MHz, CDCl3) δ 5.92 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.35 (dq, J = 
17.2, 1.5 Hz, 1H), 5.26 (dq, J = 10.4, 1.3 Hz, 1H), 4.69 (qdt, J = 13.1, 5.8, 1.4 Hz, 2H), 4.12 (q, J 
= 7.1 Hz, 2H), 3.30 (dd, J = 13.9, 2.6 Hz, 1H), 3.18 (dd, J = 13.9, 0.6 Hz, 1H), 3.08 (ddd, J = 
14.0, 11.0, 5.5 Hz, 1H), 2.96 (m, 2H), 2.94–2.85 (m, 1H), 2.82 (ddd, J = 14.0, 4.6, 3.5 Hz, 1H), 
2.75 (d, J = 16.3 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 204.2, 170.2, 
170.2, 131.5, 119.1, 66.7, 61.0, 60.9, 42.5, 38.9, 38.1, 30.3, 14.2; IR (Neat Film, NaCl) 3085, 
2982, 2936, 1736, 1718, 1711, 1420, 1373, 1346, 1281, 1182, 1132, 1097, 1047, 1028, 987, 970, 
934, 870, 850, 821 cm–1; HRMS (FAB+) m/z calc’d for C13H19O5S [M+H]+: 287.0953, found 
287.0951. 
 
 
 
  
Allyl 3-(2-(ethoxycarbonyl)allyl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1g) 
Purified by column chromatography (20% Et2O in hexanes) to provide a white, waxy solid 
(431.1 mg, 69% yield); 1H NMR (500 MHz, CDCl3) δ 6.28 (d, J = 1.3 Hz, 1H), 5.91 (ddt, J = 
17.1, 10.4, 5.8 Hz, 1H), 5.58 (q, J = 1.1 Hz, 1H), 5.34 (dq, J = 17.2, 1.5 Hz, 1H), 5.26 (dq, J = 
10.4, 1.2 Hz, 1H), 4.62 (dq, J = 5.8, 1.3 Hz, 2H), 4.26–4.10 (m, 2H), 3.31 (dd, J = 13.9, 3.1 Hz, 
1H), 3.18 (dd, J = 14.2, 0.9 Hz, 1H), 3.01–2.85 (m, 2H), 2.89–2.76 (m, 2H), 2.75–2.63 (m, 2H), 
1.29 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 204.4, 169.7, 167.0, 135.8, 131.5, 129.3, 
119.2, 66.4, 62.5, 61.2, 43.6, 38.1, 35.2, 30.6, 14.3; IR (Neat Film, NaCl) 2982, 2938, 2908, 
1714, 1649, 1628, 1434, 1416, 1370, 1337, 1311, 1294, 1278, 1262, 1194, 1175, 1156, 1117, 
S
O
CO2allyl
CO2Et
S
O
CO2allyl
CO2Et
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1096, 1058, 1025, 947, 860, 812, 683 cm–1; HRMS (FAB+) m/z calc’d for C15H21O5S [M+H]+: 
313.1110, found 313.1115.  
 
2-Methylallyl 3-benzyl-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1h) 
Purified by column chromatography (15% Et2O in hexanes) to provide a colorless oil (301.2 mg, 
49.5% yield); 1H NMR (500 MHz, CDCl3) δ 7.34–7.11 (m, 5H), 4.93 (dt, J = 12.0, 1.5 Hz, 2H), 
4.47 (s, 2H), 3.35 (d, J = 13.7 Hz, 1H), 3.31–3.24 (m, 1H), 3.11 (d, J = 13.7 Hz, 1H), 2.99–2.82 
(m, 4H), 2.85–2.73 (m, 1H), 1.68 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 204.8, 170.0, 139.1, 
135.7, 130.6, 128.3, 127.1, 114.2, 69.0, 64.3, 43.6, 39.9, 38.1, 30.7, 19.7; IR (Neat Film, NaCl) 
3084, 3062, 3029, 2924, 1713, 1657, 1495, 1454, 1432, 1378, 1364, 1329, 1311, 1275, 1262, 
1230, 1190, 1132, 1117, 1092, 1076, 1046, 1032, 965, 912, 810, 771, 741, 702 cm–1; HRMS 
(FAB+) m/z calc’d for C17H21O3S [M+H]+: 305.1211, found 305.1220.  
 
  
Allyl 3-(4-methylbenzyl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1i) 
Purified by column chromatography (15% Et2O in hexanes) to provide a white solid (299.4 mg, 
49% yield); 1H NMR (500 MHz, CDCl3) δ 7.09 – 6.95 (m, 4H), 5.83 (ddt, J = 17.1, 10.4, 5.9 Hz, 
1H), 5.29 (dq, J = 17.2, 1.5 Hz, 1H), 5.24 (dq, J = 10.4, 1.2 Hz, 1H), 4.64–4.54 (m, 2H), 3.33–
3.22 (m, 2H), 3.08 (d, J = 13.8 Hz, 1H), 2.97–2.78 (m, 4H), 2.75 (d, J = 13.9 Hz, 1H), 2.31 (s, 
3H); 13C NMR (101 MHz, CDCl3) δ 205.0, 170.0, 136.7, 132.5, 131.5, 130.5, 129.0, 119.3, 66.3, 
64.3, 43.6, 39.4, 38.0, 30.7, 21.12; IR (Neat Film, NaCl) 2922, 1710, 1514, 1422, 1359, 1272, 
1229, 1181, 1112, 1048, 967, 931, 828 cm–1; HRMS (FAB+) m/z calc’d for C17H21O3S [M+H]+: 
305.1211, found 305.1208.;  
 
 
 
 
S
O
O
O
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O
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Allyl 3-(4-bromobenzyl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1j) 
Purified by column chromatography (15% Et2O in hexanes) to provide a white solid (502.0 mg, 
68% yield); 1H NMR (500 MHz, CDCl3) δ 7.39–7.31 (m, 2H), 7.09–7.02 (m, 2H), 5.79 (ddt, J = 
17.2, 10.4, 5.9 Hz, 1H), 5.32–5.16 (m, 2H), 4.61–4.49 (m, 2H), 3.33–3.22 (m, 2H), 3.01 (d, J = 
13.7 Hz, 1H), 2.98–2.78 (m, 4H), 2.73 (d, J = 13.8 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 
204.7, 169.8, 134.8, 132.4, 131.4, 131.2, 121.2, 119.5, 66.4, 64.2, 43.6, 39.2, 38.3, 30.8; IR (Neat 
Film, NaCl) 2926, 1711, 1488, 1426, 1359, 1311, 1295, 1271, 1230, 1190, 1108, 1072, 1048, 
1012, 968, 937, 832, 792, 711, 682, 624 cm–1; HRMS (FAB+) m/z calc’d for C16H16O3S81Br 
[(M+H)-H2]+: 368.9983, found 368.9967. 
 
 
 
  
Allyl 3-(4-fluorobenzyl)-4-oxotetrahydro-2H-thiopyran-3-carboxylate (1k) 
Purified by column chromatography (15% Et2O in hexanes) to provide a colorless oil (383.7.5 
mg, 62% yield); 1H NMR (500 MHz, CDCl3) δ 7.18 – 7.10 (m, 2H), 6.97 – 6.88 (m, 2H), 5.79 
(ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.31–5.19 (m, 2H), 4.61–4.49 (m, 2H), 3.33 (d, J = 13.8 Hz, 
1H), 3.26 (dd, J = 13.9, 2.7 Hz, 1H), 3.03 (d, J = 13.8 Hz, 1H), 2.99–2.77 (m, 4H), 2.74 (d, J = 
13.9 Hz, 1H); 19F NMR (282 MHz, CDCl3) δ –115.82 (tt, J = 8.6, 5.4 Hz); 13C NMR (101 MHz, 
CDCl3) δ 204.9, 169.8, 163.3, 160.8, 132.2 (d, J = 7.9 Hz), 131.5 (d, J = 3.3 Hz), 115.1 (d, J = 
20.9 Hz), 66.3, 64.4 (2C), 43.6, 39.0, 38.3, 30.8; IR (Neat Film, NaCl) 2928, 1709, 1601, 1508, 
1421, 1273, 1221, 1185, 1158, 1116, 1100, 1048, 1016, 934, 840 cm–1; HRMS (FAB+) m/z 
calc’d for C16H18O3SF [M+H]+: 309.0961, found 309.0958. 
 
 
 
S
O
CO2allyl
Br
S
O
CO2allyl
F
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Allyl 4-oxo-3-(4-(trifluoromethyl)benzyl)tetrahydro-2H-thiopyran-3-carboxylate (1l) 
Purified by column chromatography (15% Et2O in hexanes) to provide a white solid (481.9 mg, 
67% yield); 1H NMR (400 MHz, CDCl3) δ 7.55–7.43 (m, 2H), 7.34–7.27 (m, 2H), 5.74 (ddt, J = 
17.2, 10.4, 6.0 Hz, 1H), 5.29–5.14 (m, 2H), 4.53 (dq, J = 6.0, 1.5 Hz, 2H), 3.41 (d, J = 13.6 Hz, 
1H), 3.27 (dd, J = 13.8, 2.7 Hz, 1H), 3.07 (d, J = 13.6 Hz, 1H), 3.02–2.77 (m, 4H), 2.75 (d, J = 
13.8 Hz, 1H); 19F NMR (282 MHz, CDCl3) δ –62.57; 13C NMR (101 MHz, CDCl3) δ 204.6, 
169.7, 140.1 (d, J = 1.5 Hz), 131.0 (2C), 129.4 (q, J = 32.3 Hz), 125.1 (q, J = 3.8 Hz), 122.9 (q, J 
= 272.7 Hz) 119.5, 66.4, 64.3, 43.6, 39.6, 38.5, 30.8; IR (Neat Film, NaCl) 2929, 1715, 1618, 
1420, 1326, 1293, 1276, 1232, 1191, 1165, 1114, 1068, 1020, 969, 939, 855, 732, 684, 630, 607 
cm–1; HRMS (FAB+) m/z calc’d for C17H18O3SF3 [M+H]+: 359.0929, found 359.0939. 		
Derivatization of Alkylation Products 
 
 
 
(R)-4-benzyl-7-hydroxy-4-methylheptan-3-one (3) 
To an oven dried vial was added a 1 M solution of BH3•THF (0.25 mmol, 250 µL) and the vial 
cooled to 0 °C.  Cyclohexene (0.5 mmol, 50.6 µL) was then added neat dropwise and the mixture 
stirred for 1 h at 0 °C.  A solution of 2a (0.2 mmol, 49.2 mg) in 1.0 mL THF was then added, the 
cooling bath removed, and the reaction continued at room temperature for 4h.  Water (500 µL) 
was then added followed by NaBO3•4H2O (1.0 mmol, 153.9 mg), and the reaction continued at 
room temperature for 12h at which point the reaction was diluted with water and extracted with 
Et2O.  The combined organic layers were dried with Na2SO4 and concentrated.  The crude 
reaction mixture was then dissolved in 3 mL of EtOH, treated with a suspension of Raney Ni 
(1.0 mL settled volume) and to 70 °C for 2h.  The reaction was then allowed to settle, and the 
S
O
CO2allyl
CF3
S
O O
Bn Me
OH
1) BH3•THF, cyclohexene
THF, 0 °C to 25 °C, 4h
then NaBO3•4H2O, 16h
2) RaNi, EtOH, 70 °C, 2h
94% yield over 2 steps
Bn
2a 3
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supernatant removed via pipette and filtered through a plug of Celite®.  Additional EtOH was 
added to the reaction vial and stirred for ~5 mins before again being allowed to settle and the 
supernatant removed.  This process was repeated an additional two times, and the combined 
filtrates concentrated.  The crude residue was purified by column chromatography (30% EtOAc 
in hexanes) to afford the desired linear alcohol (43.9 mg, 94% yield over two steps); [α]D25 -20.4 
(c 1.39, CHCl3);1H NMR (500 MHz, CDCl3) δ 7.27–7.16 (m, 3H), 7.05 (d, J = 7.0 Hz, 2H), 3.59 
(h, J = 4.5 Hz, 2H), 2.95 (d, J = 13.3 Hz, 1H), 2.66 (d, J = 13.3 Hz, 1H), 2.42 (dq, J = 18.5, 7.1 
Hz, 1H), 2.26 (dq, J = 18.4, 7.1 Hz, 1H), 1.82 (td, J = 11.3, 10.5, 2.9 Hz, 1H), 1.61 (s, 1H), 1.55 
– 1.36 (m, 3H), 1.13 (s, 3H), 0.97 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 216.3, 
137.6, 130.3, 128.2, 126.5, 63.1, 51.8, 45.3, 34.9, 32.2, 28.0, 20.7, 7.8; IR (Neat Film, NaCl) 
3421 (br), 3029, 2972, 2938, 1701, 1496, 1454, 1409, 1378, 1352, 1097, 1059, 1031, 1019, 973, 
753, 703 cm–1; HRMS (MM) m/z calc’d for C15H23O2 [M+H]+: 235.1693, found 235.1685. 
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Additional Ligand Screen Results 
 
 
 
S
O
CO2allyl
S
O
Pd2(dba)3 (2.5 mol %)
ligand (6 mol %)
toluene, 25 °C, 24 h
Bn
entry
6
1
2
7
3
ligand
4
(R)-BINAP
(S)-DTBM-BIPHEP
e.e
9
22
(R)-BTFM-Garphos
5
NR
–17
8 (R)-PhanePhos –7
9
10
(R)-SDP
(S,S,S)-(-)-Ph-SKP
–3
25
11 (R,R)-Chiraphos low conv
(R)-SEGPHOS
(S)-C3-TunePhos
(R)-P-Phos
19
–16
(R)-bis(Diisopropylphosphino)-SEGPHOS low conv
17
12
13
18
14
15
(S,S)-BDPP
catASium D(R)
27
28
(S,S)-BPPM
16
12
23
19 (R,R)-Me-DuPhos low conv
20
21
(S,S)-Et-Ferrotane
(1R,1'R,2S,2'S)– DuanPhos
–6
29
22 (S)–BINAPINE –15
(S,S)-Et-BPE
(R,R)-Norphos
(S,S)-Me-Ferrocelane
10
–1
R,R-Me2NXylFR NR
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entry
28
23
29
25
ligand
26
(R)-(S)-Ph, Cy Josiphos (J-001-1)
(R)-(R)-Ph, Ph Walphos (W-002-1)
e.e
–6
10
(R)-(R)-Ph, XylF Walphos (W-001-1)
27
low conv
19
30
(R,R)–ChenPHOS 631
(S)-Quinap low conv32
(S)-(R)-Ph Mandyphos (M-001-2)
(R)-(R)-Ph, Norbornyl Walphos (W-022-1)
(R)-(R)-Ph, Ph Taniaphos (T-001-1)
8
–17
(S)-(R)-XylF Mandyphos (M-003-2) NR
34
35
33 (S,S)-CpFe(4-iPr-oxazolinyl)C5H3PPh2 38
–16
36
(R)-Difluorphos
Josiphos (SL-J212-1) 1
(R)-Synphos –12
24 (R)-(S)-MeOMe2C6H2, Cy Josiphos (SL-J007-1) –13.6
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Determination of Absolute Configuration of Alkylation Product 2a 
Experimental Protocol.  Samples (15.2 mg each) of 2a (generated from the reaction of 1a and 
(R,R)-L5; Scheme 1, entry 5) and ent-2a (generated from 1a and (S,S)-L5) were subjected to 
absolute configuration determination via vibrational circular dichroism (VCD) using a ChiralIR-
2X spectrometer (BioTools, Inc) at 4 cm–1 resolution and optimized at 1400 cm–1.  Each sample 
was dissolved in 280 µL of CDCl3 (54 mg/mL), loaded into an SL-4 cell (International Crystal 
Laboratories) with BaF2 windows and 100 µm path length, and infrared (IR) and VCD spectra 
acquired in 24 one-hour blocks which were averaged at the completion of the run.  A 15-minute 
acquisition of neat (+)-α-pinene control yielded a VCD spectrum in agreement with literature 
spectra.  IR and VCD spectra were background-corrected using a 5-minute block acquisition of 
the empty instrument chamber.  IR spectra of 2a and ent-2a were solvent corrected utilizing a 1-
hour block acquisition of CDCl3.  VCD spectra of 2a and ent-2a were enantiomer subtracted 
(half-difference). 
Computational Protocol.  The arbitrarily chosen (S) enantiomer of 2a was subjected to an 
exhaustive initial molecular mechanics-based conformational search (MMFF94 force field, 0.08 
Å geometric RMSD cutoff, and 30 kcal/mol energy window) as implemented in MOE (Chemical 
Computing Group, Montreal, CA).  All conformers retained the (S) configuration.  All MMFF94 
conformers were then subjected to geometry optimization, harmonic frequency calculation, and 
VCD rotational strength evaluation with density functional theory.  All quantum mechanical 
calculations utilized the B3PW91 functional, cc-pVTZ basis, and implicit IEFPCM chloroform 
solvation model as implemented in the Gaussian 09 program system (Rev. E.01; Frisch et al., 
Gaussian, Inc., Wallingford, CT).  Resultant harmonic frequencies were scaled by 0.98.	 All 
structurally unique conformers were Boltzmann weighted by relative free energy at 298.15 K.  
The predicted IR and VCD frequencies and intensities were convolved using Lorentzian line 
shapes (γ = 4 cm–1) and summed using the respective Boltzmann weights to yield the final 
predicted IR and VCD spectra of the (S) enantiomer of 2a.  The predicted VCD of the 
corresponding (R) enantiomer was generated by inversion of sign.  From the excellent agreement 
between the predicted and measured IR and VCD spectra (see below) the absolute configuration 
of 2a was unambiguously established as (S). 
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Experimental (top) and computed (bottom) IR and VCD spectra for 2a and ent-2a. 
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